Medication-related osteonecrosis of the jaw is an uncommon but highly morbid adverse event of certain medical therapies. Although classically induced by bisphosphonates, the recent advent of monoclonal antibodies is contributing to a rise in cases. In this case report, we present a rare case of golimumab-associated medication-related osteonecrosis of the jaw and discuss the possible mechanisms of pathogenesis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.oooo.2023.05.017 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!